Last reviewed · How we verify
NCT02891317
Assessing Ocular Hemodynamic Response to Surgical Intervention in Glaucoma
trial in Primary Open Angle Glaucoma in 2 participants. Terminated before completion.
12 June 2017
Quick facts
| Lead sponsor | University of North Carolina, Chapel Hill |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 2 |
| Start date | 8 May 2017 |
| Primary completion | 12 June 2017 |
| Estimated completion | 12 June 2017 |
| Sites | 1 location across United States |
Conditions studied
- Primary Open Angle Glaucoma — all drugs for Primary Open Angle Glaucoma →
- Low Tension Glaucoma — all drugs for Low Tension Glaucoma →
- Cataract — all drugs for Cataract →
- Ocular Hypertension — all drugs for Ocular Hypertension →
Sponsor
University of North Carolina, Chapel Hill
Who can join
18 and older, any sex, with Primary Open Angle Glaucoma or Low Tension Glaucoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to assess how surgical interventions in glaucoma affect 24-hour intraocular pressure, 24-hour ocular perfusion pressure, optic nerve blood flow, and retinal oxygen saturation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT02891317
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Primary Open Angle Glaucoma
Currently open trials in the same condition.
- NCT07390890 — DSLT for Reducing Medication in Glaucoma · recruiting
- NCT07447011 — Glaucoma Respsosne to Lifestyle Corrections in Sleep Apnea · NA · recruiting
- NCT07358650 — Clinical Study Evaluating the Safety and Performance of the MIST Device for Intraocular Pressure Reduction in Patients W · NA · recruiting
- NCT06948773 — A Study of the Helix Surgical System in Primary Open-Angle Glaucoma (POAG) and Cataract (HELIX) · NA · recruiting
- NCT05439161 — XEN Glaucoma Gel Stent Versus Trabeculectomy · NA · recruiting
Other University of North Carolina, Chapel Hill trials
Trials by the same sponsor.
- NCT06841913 — Woodsmoke Exposure, Influenza Infection, and Nasal Immunity · Phase 4 · suspended
- NCT07383428 — The INICIO-Guatemala Study · NA · not yet recruiting
- NCT07528443 — Ultraprocessed Foods in Colombia · NA · not yet recruiting
- NCT07507370 — CARED : A Novel Rapid Treatment Paradigm for Depression · NA · not yet recruiting
- NCT07534254 — Piloting a Generative Artificial Intelligence Chatbot in a Mobile Weight Loss Program · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02891317 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of North Carolina, Chapel Hill
- Last refreshed: 5 March 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02891317.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing